Cited by 1,505Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer, Lipids, and Metabolism

Cancer metabolism: a therapeutic perspective

Open access
Martinez-Outschoorn, Ubaldo E., Peiris-Pagés, Maria, Pestell, Richard G., Sotgia, Federica, Lisanti, Michael P.·2017·Nature Reviews Clinical Oncology

Abstract

Awareness that the metabolic phenotype of cells within tumours is heterogeneous - and distinct from that of their normal counterparts - is growing. In general, tumour cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine, and fatty acids at much higher rates than their nontumour equivalents; however, the metabolic ecology of tumours is complex because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites. This metabolic variability and flexibility enables tumour cells to generate ATP as an energy source, while maintaining the reduction-oxidation (redox) balance and committing resources to biosynthesis - processes that are essential for cell survival, growth, and proliferation. Importantly, experimental evidence indicates that metabolic coupling between cell populations with different, complementary metabolic profiles can induce cancer progression. Thus, targeting the metabolic differences between tumour and normal cells holds promise as a novel anticancer strategy. In this Review, we discuss how cancer cells reprogramme their metabolism and that of other cells within the tumour microenvironment in order to survive and propagate, thus driving disease progression; in particular, we highlight potential metabolic vulnerabilities that might be targeted therapeutically.

Integrity signals

Registry

Crossref · 10.1038/nrclinonc.2016.60

Cites

228 of 228 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Malignant cells share a common metabolic trait, namely that they can acquire and use nutrients from a predominantly nutrient-poor environment.

    “Notwithstanding the diversity of cancers, malignant cells share a common metabolic trait, namely that they can acquire and use nutrients from a predominantly nutrient-poor environment, a modus operandi that emerged as a promising target to battle tumors (202–205).”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P.
Affiliations
  • Thomas Jefferson University (US)
  • University of Manchester (GB)
Corresponding author
  • Sotgia, Federica
  • Lisanti, Michael P.
Venue
Nature Reviews Clinical Oncology
Published
2016-05-04
Volume
14
Issue
1
Pages
11-31
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W2345381093
Cited by
1,505
References
228
Citations by year
2026: 95 · 2025: 137 · 2024: 153 · 2023: 162 · 2022: 170 · 2021: 180 · 2020: 190 · 2019: 155 · 2018: 134 · 2017: 107 · 2016: 19
FWCI
12.70
Type
journal article
Language
en
Update notices
erratum (2017-01-17)
Open access
Locations
  • Nature Reviews Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • University of Salford Institutional Repository (University of Salford) (submittedVersion, cc-by)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
cancer metabolism, metabolic reprogramming, tumor microenvironment, metabolic heterogeneity, glucose metabolism, glutamine metabolism, fatty acid metabolism, redox homeostasis, metabolic coupling, metabolic vulnerability, anticancer drug targets, tumor progression
MeSH terms
Mitochondrial Ribosomes, Acetyl Coenzyme A, Adaptation, Physiological, Amino Acids, Antineoplastic Agents, Antioxidants, Autophagy, Blood Glucose, Energy Metabolism, Fatty Acids, Glutamine, Humans, Ketone Bodies, Lipids, Mitochondria, Neoplasms, Nucleic Acids, Transcription Factors, Oxidative Stress, Glutamic Acid, Genetic Heterogeneity, Pyruvic Acid, Lactic Acid, Epigenomics, TOR Serine-Threonine Kinases, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review